Home
Categories
EXPLORE
True Crime
Comedy
Society & Culture
Business
Sports
History
Fiction
About Us
Contact Us
Copyright
© 2024 PodJoint
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts122/v4/56/ff/06/56ff0683-0cfb-bdb4-0abc-347b91c3e645/mza_8877694434773236132.png/600x600bb.jpg
Hematology / Oncology @Point of Care Podcasts
@Point of Care
81 episodes
4 months ago
Our @Point of Care Hematology & Oncology Podcasts have healthcare experts discussing and providing information related to oncology diagnosis, treatment, management, and other important information.
Show more...
Health & Fitness
Medicine
RSS
All content for Hematology / Oncology @Point of Care Podcasts is the property of @Point of Care and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Our @Point of Care Hematology & Oncology Podcasts have healthcare experts discussing and providing information related to oncology diagnosis, treatment, management, and other important information.
Show more...
Health & Fitness
Medicine
Episodes (20/81)
Hematology / Oncology @Point of Care Podcasts
S25:E2 – Managing RET Fusion-Positive NSCLC
4 months ago
27 minutes 18 seconds

Hematology / Oncology @Point of Care Podcasts
S25:E1 – ALK-Positive NSCLC: Navigating the Treatment Landscape
4 months ago
26 minutes 49 seconds

Hematology / Oncology @Point of Care Podcasts
S24:E3 – Evidence-Based Strategies for Individualizing CAR T-Cell Therapy in Patients With RRMM
4 months ago
22 minutes 41 seconds

Hematology / Oncology @Point of Care Podcasts
S24:E2 – Identifying Patients for CAR T-Cell Therapy in Earlier Treatment Lines for RRMM
4 months ago
23 minutes 32 seconds

Hematology / Oncology @Point of Care Podcasts
CAR T-Cell Therapy Earlier in Treatment for RRMM
4 months ago
22 minutes 52 seconds

Hematology / Oncology @Point of Care Podcasts
S23:E3 – Staying the Course in Metastatic Breast Cancer
4 months ago
28 minutes 54 seconds

Hematology / Oncology @Point of Care Podcasts
S23:E2 – Mapping the Pathway in Metastatic Breast Cancer
4 months ago
29 minutes 3 seconds

Hematology / Oncology @Point of Care Podcasts
S23:E1 – Testing the Waters in Metastatic Breast Cancer
4 months ago
29 minutes 34 seconds

Hematology / Oncology @Point of Care Podcasts
S22:E3 – Compare Your TROP2-directed ADC in Non-Small Cell Lung Cancer Treatment-Related Adverse Events Management Plan to the Experts
5 months ago
26 minutes 4 seconds

Hematology / Oncology @Point of Care Podcasts
S22:E2 – Advances in TROP2-directed ADCs for Non-Small Cell Lung Cancer: First-Line and Combination Therapies
5 months ago
25 minutes 53 seconds

Hematology / Oncology @Point of Care Podcasts
S22:E1 – TROP2-directed ADCs in the Second Line: Updates from Clinical Trials in NSCLC
5 months ago
27 minutes 53 seconds

Hematology / Oncology @Point of Care Podcasts
S21:E2 – Individualizing Care Plans for Patients With AML
1 year ago
24 minutes 25 seconds

Hematology / Oncology @Point of Care Podcasts
S21:E1 – Improving Survival With HMA Maintenance Therapy in AML
1 year ago
42 minutes 27 seconds

Hematology / Oncology @Point of Care Podcasts
S20:E3 – Identifying and Managing Treatment-Related Adverse Events (TRAEs) Associated With TROP2-Targeting Therapies
1 year ago
22 minutes 43 seconds

Hematology / Oncology @Point of Care Podcasts
S20:E1 – Clinical Implications of Trophoblast-Cell Surface Antigen 2 (TROP2) in Non-Small Cell Lung Cancer (NSCLC)
1 year ago
26 minutes 19 seconds

Hematology / Oncology @Point of Care Podcasts
S20:E2 – Latest Clinical Trial Data of Emerging, TROP2-Targeting Agents in Advanced NSCLC
1 year ago
30 minutes 30 seconds

Hematology / Oncology @Point of Care Podcasts
S19:E3 – Morning Commute Podcast: What Clinicians Should Know about Treatment-Related Adverse Events from HER3-Directed ADCs in Breast and Lung Cancer
1 year ago
26 minutes 12 seconds

Hematology / Oncology @Point of Care Podcasts
S19:E2 – Morning Commute Podcast: A Review of Trial Data on HER3 in Non-Small Cell Lung Cancer and Breast Cancer
1 year ago
30 minutes 48 seconds

Hematology / Oncology @Point of Care Podcasts
S19:E1 – Morning Commute Podcast: Should HER3 Be Considered a Tumor-Agnostic Target in Breast and Lung Cancer?
1 year ago
25 minutes 35 seconds

Hematology / Oncology @Point of Care Podcasts
S18:E3 – Morning Commute Podcast: Biomarker Testing in HR+ Breast Cancer—If the Shoe Fits
1 year ago
28 minutes 3 seconds

Hematology / Oncology @Point of Care Podcasts
Our @Point of Care Hematology & Oncology Podcasts have healthcare experts discussing and providing information related to oncology diagnosis, treatment, management, and other important information.